Trademark Attorney / Law Firm
Amber N. Davis, Esquire – Trademark Portfolio
Amber N. Davis, Esquire has filed 5 trademarks with the United States Patent and Trademark Office (USPTO). Filing records span from 2000 to 2012, covering 2 years of intellectual property practice. Of these filings, 1 is currently registered. The portfolio covers 2 Nice Classification classes, with the highest concentration in Class 9 (Computers & Electronics, 2 filings) and Class 5 (Pharmaceuticals, 2 filings).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Amber N. Davis, Esquire's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has Amber N. Davis, Esquire filed?
Amber N. Davis, Esquire has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 abandoned, 3 cancelled.
What trademark classes does Amber N. Davis, Esquire specialize in?
Amber N. Davis, Esquire has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
How long has Amber N. Davis, Esquire been filing trademarks?
Amber N. Davis, Esquire's trademark filing history with the USPTO spans from 2000 to 2012, covering 12 years of trademark practice. During this period, Amber N. Davis, Esquire has handled 5 trademark applications.
What is Amber N. Davis, Esquire's trademark registration success rate?
Amber N. Davis, Esquire has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.